QQQ   375.47 (+0.76%)
AAPL   148.76 (+1.51%)
MSFT   308.23 (+0.31%)
FB   339.99 (+1.39%)
GOOGL   2,864.74 (+0.32%)
TSLA   864.27 (-0.67%)
AMZN   3,444.15 (-0.08%)
NVDA   222.90 (+0.31%)
BABA   177.00 (+6.10%)
NIO   40.03 (+1.06%)
CGC   14.34 (+8.64%)
GE   104.73 (+0.59%)
AMD   116.33 (-0.09%)
MU   67.57 (+0.46%)
T   25.59 (+1.03%)
F   15.42 (-0.90%)
ACB   7.45 (+7.66%)
DIS   171.18 (+0.02%)
PFE   42.09 (+1.86%)
BA   215.97 (-0.47%)
AMC   40.80 (-5.18%)
QQQ   375.47 (+0.76%)
AAPL   148.76 (+1.51%)
MSFT   308.23 (+0.31%)
FB   339.99 (+1.39%)
GOOGL   2,864.74 (+0.32%)
TSLA   864.27 (-0.67%)
AMZN   3,444.15 (-0.08%)
NVDA   222.90 (+0.31%)
BABA   177.00 (+6.10%)
NIO   40.03 (+1.06%)
CGC   14.34 (+8.64%)
GE   104.73 (+0.59%)
AMD   116.33 (-0.09%)
MU   67.57 (+0.46%)
T   25.59 (+1.03%)
F   15.42 (-0.90%)
ACB   7.45 (+7.66%)
DIS   171.18 (+0.02%)
PFE   42.09 (+1.86%)
BA   215.97 (-0.47%)
AMC   40.80 (-5.18%)
QQQ   375.47 (+0.76%)
AAPL   148.76 (+1.51%)
MSFT   308.23 (+0.31%)
FB   339.99 (+1.39%)
GOOGL   2,864.74 (+0.32%)
TSLA   864.27 (-0.67%)
AMZN   3,444.15 (-0.08%)
NVDA   222.90 (+0.31%)
BABA   177.00 (+6.10%)
NIO   40.03 (+1.06%)
CGC   14.34 (+8.64%)
GE   104.73 (+0.59%)
AMD   116.33 (-0.09%)
MU   67.57 (+0.46%)
T   25.59 (+1.03%)
F   15.42 (-0.90%)
ACB   7.45 (+7.66%)
DIS   171.18 (+0.02%)
PFE   42.09 (+1.86%)
BA   215.97 (-0.47%)
AMC   40.80 (-5.18%)
QQQ   375.47 (+0.76%)
AAPL   148.76 (+1.51%)
MSFT   308.23 (+0.31%)
FB   339.99 (+1.39%)
GOOGL   2,864.74 (+0.32%)
TSLA   864.27 (-0.67%)
AMZN   3,444.15 (-0.08%)
NVDA   222.90 (+0.31%)
BABA   177.00 (+6.10%)
NIO   40.03 (+1.06%)
CGC   14.34 (+8.64%)
GE   104.73 (+0.59%)
AMD   116.33 (-0.09%)
MU   67.57 (+0.46%)
T   25.59 (+1.03%)
F   15.42 (-0.90%)
ACB   7.45 (+7.66%)
DIS   171.18 (+0.02%)
PFE   42.09 (+1.86%)
BA   215.97 (-0.47%)
AMC   40.80 (-5.18%)
NASDAQ:TRVI

Trevi Therapeutics News Headlines

$1.19
+0.01 (+0.85 %)
(As of 10/19/2021 12:00 AM ET)
Add
Compare
Today's Range
$1.10
$1.29
50-Day Range
$1.18
$2.10
52-Week Range
$1.10
$3.98
Volume668,510 shs
Average Volume166,480 shs
Market Capitalization$25.70 million
P/E RatioN/A
Dividend YieldN/A
Beta-0.1

Media Mentions By Week

Trevi Therapeutics Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

TRVI
News Sentiment

0.40

0.36

Average
Medical
News Sentiment

Media Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

TRVI Articles
This Week

3

0

TRVI Articles
Average Week

Get Trevi Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for TRVI and its competitors with MarketBeat's FREE daily newsletter.

Trevi Therapeutics (NASDAQ TRVI) News Headlines Today

SourceHeadline
MarketBeat logoTrevi Therapeutics, Inc. (NASDAQ:TRVI) Short Interest Update
americanbankingnews.com - October 18 at 9:01 AM
finance.yahoo.com logoTrevi Therapeutics to Present at 11th World Congress on Itch (WCI)
finance.yahoo.com - October 13 at 5:44 PM
MarketBeat logoOncotelic Therapeutics (OTCMKTS:OTLC) & Trevi Therapeutics (NASDAQ:TRVI) Head to Head Analysis
americanbankingnews.com - October 13 at 3:16 AM
markets.businessinsider.com logoTrevi Therapeutics Participating in Alliance Global Partners' Virtual Biotech & Specialty Pharma Conference
markets.businessinsider.com - October 7 at 4:15 PM
MarketBeat logoTrevi Therapeutics, Inc. (NASDAQ:TRVI) Short Interest Up 43.1% in September
americanbankingnews.com - October 4 at 4:40 AM
finance.yahoo.com logoTrevi Therapeutics Announces $11.8 Million Private Placement Priced At-the-Market
finance.yahoo.com - September 30 at 9:04 PM
nasdaq.com logoTrevi Therapeutics Inc Shares Approach 52-Week Low - Market Mover
nasdaq.com - September 22 at 10:23 AM
msn.com logoThere's a Secret Archaeological Site Under the Trevi Fountain in Rome
msn.com - September 10 at 9:18 PM
finance.yahoo.com logoTrevi Therapeutics Announces Second Quarter 2021 Financial Results and Business Update
finance.yahoo.com - August 12 at 9:08 PM
finance.yahoo.com logoTrevi Therapeutics Announces Additions to the Senior Leadership Team
finance.yahoo.com - August 9 at 5:39 PM
finance.yahoo.com logoTrevi Therapeutics to Report Q2 2021 Financial Results on August 12
finance.yahoo.com - August 5 at 5:30 PM
msn.com logoPalton Morgan Signs Piling Contract with Trevi Foundation for Paramount Twin Towers
msn.com - June 30 at 12:47 AM
msn.com logoMexican pop star Gloria Trevi ate at San Antonio's Cuishe over the weekend
msn.com - June 14 at 8:37 PM
finance.yahoo.com logoTrevi Therapeutics to Present at 2021 BIO Digital Conference
finance.yahoo.com - June 9 at 9:59 AM
msn.com logoGloria Trevi Renews Universal Music Latino Contract: Exclusive
msn.com - April 8 at 1:15 PM
finance.yahoo.com logoTrevi Therapeutics to Present at 20th Annual Needham Virtual Healthcare Conference
finance.yahoo.com - April 7 at 8:51 AM
finance.yahoo.com logoTrevi Therapeutics Announces Fourth Quarter and Year End 2020 Financial Results and Business Updates
finance.yahoo.com - March 25 at 8:49 PM
finance.yahoo.com logoTrevi Therapeutics to Report Q4 and Year End 2020 Financial Results on March 25
finance.yahoo.com - March 19 at 5:26 AM
msn.com logoGloria Trevi Dedicates Premio La Trayectoria Win to God & Family at Premio Lo Nuestro 2021
msn.com - February 19 at 12:02 AM
finance.yahoo.com logoTrevi Therapeutics to Present at 10th Annual SVB Leerink Global Healthcare Conference
finance.yahoo.com - February 18 at 7:01 PM
finance.yahoo.com logoTrevi Therapeutics' (TRVI) Shares March Higher, Can It Continue?
finance.yahoo.com - February 3 at 12:48 PM
finance.yahoo.com logoTrevi Therapeutics Appoints William Forbes, Pharm.D. as Chief Development Officer
finance.yahoo.com - February 1 at 8:31 AM
in.reuters.com logoTrevi Therapeutics Inc (TRVI.OQ)
in.reuters.com - December 4 at 9:09 PM
seekingalpha.com logoTrevi Therapeutics' (TRVI) CEO Jennifer Good on Q3 2020 Results - Earnings Call Transcript
seekingalpha.com - November 12 at 12:14 AM
seekingalpha.com logoTrevi Therapeutics reports Q3 results
seekingalpha.com - November 11 at 7:14 PM
finance.yahoo.com logoTrevi Therapeutics, Inc. to Host Earnings Call
finance.yahoo.com - November 11 at 7:14 PM
finance.yahoo.com logoTrevi Therapeutics Announces Third Quarter 2020 Financial Results and Business Update
finance.yahoo.com - November 11 at 7:14 PM
finance.yahoo.com logoTrevi Therapeutics to Report Q3 2020 Financial Results on November 11
finance.yahoo.com - November 4 at 6:45 PM
finance.yahoo.com logoIs Trevi Therapeutics (NASDAQ:TRVI) In A Good Position To Deliver On Growth Plans?
finance.yahoo.com - November 3 at 7:11 PM
finance.yahoo.com logoKaskela Law LLC Announces Stockholder Investigation of Trevi Therapeutics, Inc. - TRVI
finance.yahoo.com - October 31 at 12:12 PM
finance.yahoo.com logoTrevi Therapeutics Provides Clinical Trial Updates for Haduvio™
finance.yahoo.com - October 21 at 8:11 AM
reuters.com logoTRVI.OQ - Trevi Therapeutics Inc Profile | Reuters
reuters.com - October 19 at 5:20 PM
markets.businessinsider.com logoTrevi Therapeutics Announces the Hiring of Key Talent
markets.businessinsider.com - October 13 at 6:55 PM
finance.yahoo.com logoTrevi Therapeutics to Present at H.C. Wainwright Global Investment Conference
finance.yahoo.com - September 9 at 6:55 PM
finance.yahoo.com logoTrevi Therapeutics Announces Second Quarter 2020 Financial Results and Business Update
finance.yahoo.com - August 13 at 7:49 PM
nasdaq.com logoStock Alert: Trevi Therapeutics Up 30%
nasdaq.com - August 11 at 12:04 PM
finance.yahoo.com logoTrevi Therapeutics to Report Q2 2020 Financial Results on August 13
finance.yahoo.com - August 6 at 5:54 PM
finance.yahoo.com logoTrevi Therapeutics to Present at BTIG Virtual Biotechnology Conference
finance.yahoo.com - August 5 at 11:50 AM
seekingalpha.com logoTrevi Therapeutics under pressure after increasing size of Haduvio study
seekingalpha.com - July 13 at 1:49 PM
finance.yahoo.com logoTrevi Therapeutics Announces Positive Outcome of the Sample Size Re-Estimation Analysis in PRISM Trial for Severe Pruritus in Patients With Prurigo Nodularis
finance.yahoo.com - July 13 at 8:49 AM
finance.yahoo.com logoTrevi Therapeutics Announces Election of Dominick C. Colangelo to Board of Directors
finance.yahoo.com - June 30 at 5:13 PM
uk.reuters.com logoBRIEF-Trevi Therapeutics Files For Mixed Shelf Of Up To $150 Million
uk.reuters.com - June 26 at 11:09 PM
finance.yahoo.com logoTrevi Therapeutics to Present at BMO Prescriptions for Success Healthcare Virtual Conference
finance.yahoo.com - June 17 at 8:31 PM
www.businessinsider.com.au logoYouTuber Trevi Moran comes out as a transgender woman: 'I've dealt with this feeling my entire life'
www.businessinsider.com.au - June 8 at 8:48 AM
finance.yahoo.com logoTrevi Therapeutics to Hold Virtual 2020 Annual Meeting of Stockholders
finance.yahoo.com - May 29 at 5:44 PM
finance.yahoo.com logoTrevi Therapeutics Announces First Quarter 2020 Financial Results and Corporate Update
finance.yahoo.com - May 7 at 6:13 PM
finance.yahoo.com logoWill Trevi Therapeutics (NASDAQ:TRVI) Spend Its Cash Wisely?
finance.yahoo.com - May 7 at 1:13 PM
www.nasdaq.com logoTRVI Trevi Therapeutics, Inc. Common Stock
www.nasdaq.com - April 25 at 10:55 PM
finance.yahoo.com logoTREVI THERAPEUTICS TO PRESENT AT NEEDHAM HEALTHCARE CONFERENCE
finance.yahoo.com - April 8 at 7:17 PM
seekingalpha.com logoAMRN, PSTV, SRG and PBFX among midday movers
seekingalpha.com - March 31 at 4:03 PM
Get Trevi Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for TRVI and its competitors with MarketBeat's FREE daily newsletter.

This page was last updated on 10/19/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.